| David Scott James, CRNA | |
|
33 Prairie Dr, Buffalo, WY 82834-9340 | |
| (307) 620-0847 | |
| Not Available |
| Full Name | David Scott James |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 33 Prairie Dr, Buffalo, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346282316 | NPI | - | NPPES |
| Entity Name | Phelps Memorial Health Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1629035936 PECOS PAC ID: 9931011947 Enrollment ID: O20071129000753 |
News Archive
Coverage of next week's Supreme Court arguments on the health law includes a variety of takes on the key issues.
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial. Early data suggests that a combination of temsirolimus and bryostatin may be active in patients with rare forms of renal cell cancer, which are less likely to respond to other targeted therapies.
The way the liver renews itself may be simpler than what scientists had been assuming.
Cancer researchers at Mayo Clinic's campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) — a lethal tumor with no effective therapies.
› Verified 5 days ago
| Entity Name | Phelps Memorial Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871528851 PECOS PAC ID: 9931011947 Enrollment ID: O20080603000111 |
News Archive
Coverage of next week's Supreme Court arguments on the health law includes a variety of takes on the key issues.
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial. Early data suggests that a combination of temsirolimus and bryostatin may be active in patients with rare forms of renal cell cancer, which are less likely to respond to other targeted therapies.
The way the liver renews itself may be simpler than what scientists had been assuming.
Cancer researchers at Mayo Clinic's campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) — a lethal tumor with no effective therapies.
› Verified 5 days ago
| Entity Name | Sonno Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225331978 PECOS PAC ID: 7315127701 Enrollment ID: O20110201000828 |
News Archive
Coverage of next week's Supreme Court arguments on the health law includes a variety of takes on the key issues.
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial. Early data suggests that a combination of temsirolimus and bryostatin may be active in patients with rare forms of renal cell cancer, which are less likely to respond to other targeted therapies.
The way the liver renews itself may be simpler than what scientists had been assuming.
Cancer researchers at Mayo Clinic's campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) — a lethal tumor with no effective therapies.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Scott James, CRNA 33 Prairie Dr, Buffalo, WY 82834-9340 Ph: (307) 620-0847 | David Scott James, CRNA 33 Prairie Dr, Buffalo, WY 82834-9340 Ph: (307) 620-0847 |
News Archive
Coverage of next week's Supreme Court arguments on the health law includes a variety of takes on the key issues.
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial. Early data suggests that a combination of temsirolimus and bryostatin may be active in patients with rare forms of renal cell cancer, which are less likely to respond to other targeted therapies.
The way the liver renews itself may be simpler than what scientists had been assuming.
Cancer researchers at Mayo Clinic's campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) — a lethal tumor with no effective therapies.
› Verified 5 days ago
Jeffery W Edstrom, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 497 W Lott St, Buffalo, WY 82834 Phone: 307-684-5521 Fax: 307-684-5385 |